246 related articles for article (PubMed ID: 11196030)
1. Vancomycin-resistant Staphylococcus aureus occurs in South Africa.
Ferraz V; Dusé AG; Kassel M; Black AD; Ito T; Hiramatsu K
S Afr Med J; 2000 Nov; 90(11):1113. PubMed ID: 11196030
[No Abstract] [Full Text] [Related]
2. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML
Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222
[TBL] [Abstract][Full Text] [Related]
3. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin minimum inhibitory concentrations and outcome in patients with severe Staphylococcus aureus infection.
Gould IM
J Infect Dis; 2012 Mar; 205(5):864-5; author reply 865-6. PubMed ID: 22238463
[No Abstract] [Full Text] [Related]
5. Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil.
Panesso D; Planet PJ; Diaz L; Hugonnet JE; Tran TT; Narechania A; Munita JM; Rincon S; Carvajal LP; Reyes J; Londoño A; Smith H; Sebra R; Deikus G; Weinstock GM; Murray BE; Rossi F; Arthur M; Arias CA
Emerg Infect Dis; 2015 Oct; 21(10):1844-8. PubMed ID: 26402569
[TBL] [Abstract][Full Text] [Related]
6. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
Sakoulas G; Moellering RC
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
[TBL] [Abstract][Full Text] [Related]
7. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.
Huang YT; Hsiao CH; Liao CH; Lee CW; Hsueh PR
J Clin Microbiol; 2008 Mar; 46(3):1132-6. PubMed ID: 18199793
[TBL] [Abstract][Full Text] [Related]
8. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
Bennett JW; Murray CK; Holmes RL; Patterson JE; Jorgensen JH
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):437-40. PubMed ID: 18096352
[TBL] [Abstract][Full Text] [Related]
9. Audit of the management of Staphylococcus aureus bloodstream infection: gaps to be plugged.
Barry A; McNicholas S; Smyth E; Humphreys H; Fitzpatrick F
J Hosp Infect; 2010 Nov; 76(3):272-3. PubMed ID: 20435374
[No Abstract] [Full Text] [Related]
10. Protracted and recurrent methicillin-resistant Staphylococcus aureus bacteremia despite defervescence with vancomycin therapy.
Khatib R; Riederer KM; Held M; Aljundi H
Scand J Infect Dis; 1995; 27(5):529-32. PubMed ID: 8588150
[TBL] [Abstract][Full Text] [Related]
11. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Soriano A; Marco F; Martínez JA; Pisos E; Almela M; Dimova VP; Alamo D; Ortega M; Lopez J; Mensa J
Clin Infect Dis; 2008 Jan; 46(2):193-200. PubMed ID: 18171250
[TBL] [Abstract][Full Text] [Related]
12. Management of persistent bacteremia caused by methicillin-resistant Staphylococcus aureus: a survey of infectious diseases consultants.
Hageman JC; Liedtke LA; Sunenshine RH; Strausbaugh LJ; McDonald LC; Tenover FC;
Clin Infect Dis; 2006 Sep; 43(5):e42-5. PubMed ID: 16886141
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous vancomycin-resistant Staphylococcus aureus (hetero-VISA) in Singapore.
Sng LH; Koh TH; Wang GC; Hsu LY; Kapi M; Hiramatsu K
Int J Antimicrob Agents; 2005 Feb; 25(2):177-9. PubMed ID: 15664490
[No Abstract] [Full Text] [Related]
14. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
Sakoulas G; Gold HS; Cohen RA; Venkataraman L; Moellering RC; Eliopoulos GM
J Antimicrob Chemother; 2006 Apr; 57(4):699-704. PubMed ID: 16464892
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia.
Moise PA; Sakoulas G; Forrest A; Schentag JJ
Antimicrob Agents Chemother; 2007 Jul; 51(7):2582-6. PubMed ID: 17452488
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical relationship between the clinical outcome of Staphylococcus aureus bacteremia and the minimum inhibitory concentration of vancomycin.
Price J; Atkinson S; Llewelyn M; Paul J
Clin Infect Dis; 2009 Apr; 48(7):997-8. PubMed ID: 19260820
[No Abstract] [Full Text] [Related]
17. [Is the vancomycin resistance of Staphylococcus aureus left unnoticed?].
Vuento R
Duodecim; 1999; 115(19):2045-7. PubMed ID: 11941798
[No Abstract] [Full Text] [Related]
18. Clinical failure of vancomycin in a dialysis patient with methicillin-susceptible vancomycin-heteroresistant S. aureus.
Fusco DN; Alexander EL; Weisenberg SA; Mediavilla JR; Kreiswirth BN; Schuetz AN; Jenkins SG; Rhee KY
Diagn Microbiol Infect Dis; 2009 Oct; 65(2):180-3. PubMed ID: 19748429
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin-intermediate Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia.
Naimi TS; Anderson D; O'Boyle C; Boxrud DJ; Johnson SK; Tenover FC; Lynfield R
Clin Infect Dis; 2003 Jun; 36(12):1609-12. PubMed ID: 12802763
[TBL] [Abstract][Full Text] [Related]
20. Best alternative to vancomycin for serious methicillin-resistant Staphylococcus aureus infections: let's just say it.
Bush LM
Clin Infect Dis; 2011 Nov; 53(9):965-6. PubMed ID: 21880584
[No Abstract] [Full Text] [Related]
[Next] [New Search]
